ForMune
Noáin, Navarra, Spain
About ForMune
ForMune develops therapeutic vaccines based on protein Extra Domain A of fibronectin. ForMune develops molecules for subsequent license to pharmaceutical and marketing companies
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.7M
- Last round: Series Unknown (Sep 2012)
- Website: formune.es
- Phone: +34 948 31 61 57
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/formune-2538571 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.